Abstract
11029Background: Radium-223 dichloride (223RaCl2 ) is an alpha-emitting radiopharmaceutical and calcimimetic that has intrinsic bone-targeting properties. It is now approved for bone metastases fro...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
